TRK-IN-26

TRK-IN-26

• CAS Number: 2412309-52-3
• UNSPSC Description: TRK-IN-26 (compound 12) is a TRK inhibitor with potential for cancer research[1].
• Target Antigen: Trk Receptor
• Type: Reference compound
• Related Pathways: Neuronal Signaling;Protein Tyrosine Kinase/RTK
• Applications: Cancer-Kinase/protease
• Field of Research: Cancer
• Assay Protocol: https://www.medchemexpress.com/trk-in-26.html
• Solubility: 10 mM in DMSO
• Smiles: O=C(C1=CC=C(N(C2=CC=C(C=C2)F)C1=O)OC)NC3=CC=C(C(F)=C3)OC4=CC5=C(C=C4C6=CNN=C6)N(C)N=C5
• Molecular Weight: 568.53
• References & Citations: [1]Boyu Zhong, et al. Trk inhibitor as anti-cancer drug. Patent WO2020048455A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported